| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/24/2007 | US20070118925 Plastid Transit Peptides |
| 05/24/2007 | US20070118924 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 05/24/2007 | US20070118923 regulating gene expression in plants |
| 05/24/2007 | US20070118922 Novel plant promoter |
| 05/24/2007 | US20070118920 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
| 05/24/2007 | US20070118919 Inbred Corn Line PHCER |
| 05/24/2007 | US20070118918 comprising a promoter with maize endosperm-specific expression operably linked to heterologous DNA; transgenic maize plant cell; improved stress tolerance, yield, process and storage quality |
| 05/24/2007 | US20070118917 Recombinant DNA constructs and methods for controlling gene expression |
| 05/24/2007 | US20070118916 Process for the production of fine chemicals |
| 05/24/2007 | US20070117969 PTH receptor and screening assay utilizing the same |
| 05/24/2007 | US20070117766 Vigilant cells |
| 05/24/2007 | US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 05/24/2007 | US20070117748 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 05/24/2007 | US20070117747 Treating disorders of the nervous system |
| 05/24/2007 | US20070117742 producing a fraction enriched in a proteinaceous molecule having N-linked glycans comprising sialyl-Lewis X, Lewis X or LacdiNac structures; cerebral ischemia or myocardial infarction; composition comprising erythropoietin molecules |
| 05/24/2007 | US20070117206 Methods for clonal derivation of human blastocyst-derived stem cell lines |
| 05/24/2007 | US20070117205 Hepatoblasts and method of isolating same |
| 05/24/2007 | US20070117204 Culture substrate and culture method for undifferentiated cell and undifferentiated cultured cell |
| 05/24/2007 | US20070117203 Modulation of stem and progenitor cell growth by oscillatory fluid flow |
| 05/24/2007 | US20070117196 Transformed microorganism comprising an isolated fragment of DNA derived from coffee and integrated into the genome or plasmid of the mannase; involved in the hydrolysis of polysaccharides |
| 05/24/2007 | US20070117185 Method for the recombinant expression of a polypeptide |
| 05/24/2007 | US20070117184 In vivo incorporation of unnatural amino acids |
| 05/24/2007 | US20070117183 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 05/24/2007 | US20070117182 Nucleic acids conferring transcriptional responsiveness on the RANKL gene promoter and uses thereof |
| 05/24/2007 | US20070117181 pdCpA is bound to an amino acid such as phenylalanine, tryptophan or tyrosine or derivative allowed to react with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indecene-3-propionic acid label to form a labeled amino acid-pdCpA conjugate, which is then bound to tRNA(CA-); functional protein synthesis |
| 05/24/2007 | US20070117167 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 05/24/2007 | US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070117162 Kidney-specific urate transporter and gene thereof |
| 05/24/2007 | US20070117161 Antibody Specific for Human 4-1BB Receptor |
| 05/24/2007 | US20070117156 Method of detecting native proBNP |
| 05/24/2007 | US20070117146 Allelic variants of GPR50 |
| 05/24/2007 | US20070117142 Regulation of novel human asparagine-hydroxylases |
| 05/24/2007 | US20070117131 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 05/24/2007 | US20070117129 Antigen arrays for treatment of bone disease |
| 05/24/2007 | US20070117126 Shotgun scanning |
| 05/24/2007 | US20070117124 Achaete-Scute Like-2 Polypeptides and Encoding Nucleic Acids and Methods for the Diagnosis and Treatment of Tumor |
| 05/24/2007 | US20070117107 rRNA genes from E. coli and other disease causing organisms are genetically engineered to allow identification of functional mutant ribosomes that may be used as drug targets |
| 05/24/2007 | US20070117098 'signalin' family of TGFbeta signal transduction proteins and uses related thereto |
| 05/24/2007 | US20070117087 analysis and medical diagnosis of diseases using time varying electromagnetic force ("TVEMF") expanded peripheral blood stem cells |
| 05/24/2007 | US20070117086 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
| 05/24/2007 | US20070116715 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 05/24/2007 | US20070116707 Antibody and antibody fragments for inhibiting the growth of tumors |
| 05/24/2007 | US20070116703 Isolated mammalian membrane proteins; related agents |
| 05/24/2007 | US20070116701 Compositions and methods for diagnosing and treating cancer |
| 05/24/2007 | US20070116692 Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells |
| 05/24/2007 | US20070116691 Conditionally immortalized long-term stem cells and methods of making and using such cells |
| 05/24/2007 | US20070116690 Method for the generation of antigen-specific lymphocytes |
| 05/24/2007 | US20070116689 LIM mineralization protein splice variants |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116686 Method for separating precursor cells producing gabaergic neuron alone |
| 05/24/2007 | US20070116685 Endothelial progenitor cells that express CD31 and c-kit, and not more than one percent express Tie-2 antigen; cell therapy for eye disorders |
| 05/24/2007 | US20070116684 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116683 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116682 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116681 Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations |
| 05/24/2007 | US20070116680 Stem cells within gel microenvironments |
| 05/24/2007 | US20070116679 Augmentation of organ function |
| 05/24/2007 | US20070116676 Method for three-dimensional cartilage tissue engineering using bone marrow cells in tissue engineering bone marrow cells in simulated microgravity environment |
| 05/24/2007 | US20070116674 Use of adipose tisue cells for initiating the formation of a fuctional vascular network |
| 05/24/2007 | US20070116668 Lymphotoxin-beta, lymphotoxin-beta Complexes, pharmaceutical preparations and therapeutic uses thereof |
| 05/24/2007 | DE102005054940A1 Verbundmaterial, insbesondere für die medizinische Anwendung , und Verfahren zu dessen Herstellung Composite material, in particular for medical use, and methods for its preparation |
| 05/24/2007 | DE102005054938A1 Formkörper auf Basis eines vernetzten, Gelatine enthaltenden Materials, Verfahren zu deren Herstellung sowie deren Verwendung Molding based on a cross-linked, gelatinous material, process for their preparation and their use |
| 05/24/2007 | DE102005054628A1 Verfahren zur Herstellung von permanenten humanen Zelllinien A process for the production of permanent human cell lines |
| 05/24/2007 | DE102005054577A1 Verwendung von Estern ungesättigter, physiologisch aktiver Fettsäuren als Nährmedien für Zellkulturen Use of esters of unsaturated, physiologically active fatty acids as growth media for cell culture |
| 05/24/2007 | CA2630559A1 Modified pore-forming protein toxins and use thereof |
| 05/24/2007 | CA2630355A1 Extracellular matrix components for expansion or differentiation of hepatic progenitors |
| 05/24/2007 | CA2629715A1 Anti-alpha2 integrin antibodies and their uses |
| 05/24/2007 | CA2629532A1 Method of expanding double negative t cells |
| 05/24/2007 | CA2629453A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 05/24/2007 | CA2629363A1 Emp4 gene |
| 05/24/2007 | CA2629211A1 Method for the production of permanent human cell lines |
| 05/24/2007 | CA2628945A1 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 05/24/2007 | CA2626805A1 Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| 05/24/2007 | CA2626092A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/24/2007 | CA2567132A1 Process for the production of .delta.5-unsaturated fatty acids in transgenic organisms |
| 05/23/2007 | EP1788088A1 Vector expressing n-deacetylase/n-sulfotransferase 2 |
| 05/23/2007 | EP1788086A1 Death Domain Containing Receptor 5 |
| 05/23/2007 | EP1788085A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/23/2007 | EP1788079A1 Animal tissue-eccentrically located pluripotent cell proliferating selectively in low-serium medium |
| 05/23/2007 | EP1788078A1 Dentritic cell drug containing the dentritic cell, therapeutic method using the dentritic cell and method of culturing gamma delta t cell |
| 05/23/2007 | EP1788077A1 A method for creating cell clusters |
| 05/23/2007 | EP1788076A1 Use of esters of unsaturated physiologically active fatty acids as nutrient media for cell cultures |
| 05/23/2007 | EP1787999A1 Anti-VEGF antibodies |
| 05/23/2007 | EP1787997A1 MU-1, member of the cytokine receptor family |
| 05/23/2007 | EP1786910A2 Salt resistant transgenic plants |
| 05/23/2007 | EP1786897A2 Means and methods for producing a stabilized cell of interest |
| 05/23/2007 | EP1786896A1 Methods for identifying factors for differentiating definitive endoderm |
| 05/23/2007 | EP1786895A2 Tridimensional support for cell culture, culture method making use of such a support and stem-like cells obtained through such a method |
| 05/23/2007 | EP1786470A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 05/23/2007 | EP1786456A1 Use of apo2l receptor agonists and nk cells or nk cell activators |
| 05/23/2007 | EP1786439A2 Methods of activating nkt cells |
| 05/23/2007 | EP1594446A4 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING |
| 05/23/2007 | EP1364205B1 Production of a monoclonal antibody by a transgenic avian |
| 05/23/2007 | EP1144637B1 Wuschel (wus) gene homologs |
| 05/23/2007 | EP1127135B1 High fidelity thermostable ligase and uses thereof |
| 05/23/2007 | EP1056881B1 A simplified system for generating recombinant adenoviruses |
| 05/23/2007 | EP1029916B1 Human lysophosphatidic acid receptor and use thereof |
| 05/23/2007 | EP1012274B1 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| 05/23/2007 | EP0944716B1 Imidazolinone herbicide resistant sugar beet plants |